Embolx, Inc.

Embolx, Inc. is a commercial-stage medical device company based in Silicon Valley, founded in 2013. Specializing in the development of microcatheters for arterial embolization procedures, the company is dedicated to significantly enhancing the treatment of various conditions such as cancerous tumors, benign prostatic hyperplasia, and uterine fibroids. One of their key products, the Sniper balloon occlusion microcatheter, has set a new standard for precise embolic delivery and superior target filling by controlling pressure to direct blood flow while safeguarding non-target surrounding tissues.

With a focus on Health Care and Manufacturing industries, Embolx recently secured a Seed Round investment in June 17, 2019, with participation from notable investors including Life Science Angels and MedTech Innovator. This significant investment reflects the recognition and support of the company's innovative approach to revolutionizing medical treatments.